kabutan

Vitabrid Japan starts trading with sell orders at offer price on TSE Growth Market debut

Thu Apr 2, 2026 9:01 am JST Catalyst

Vitabrid Japan <542A>, which newly listed on the Tokyo Stock Exchange Growth Market today, started trading with sell orders at \1,370, the same as its initial public offering price.

The company is a subsidiary of VECTOR INC. <6058> and operates wellness care-related businesses. It primarily develops and sells inner care products centered on the functional food supplement "Terminalia First," as well as outer care skincare products containing the patented "Vitabrid C" ingredient. In November 2024, the company also launched an online medical consultation platform business, "Sustaina Online Clinic," which provides prescription pharmaceuticals through partnerships with clinics. The offering consisted of 1.64 million shares in the public offering, plus 246,000 shares in an over-allotment. SBI Securities served as the lead underwriter.

Note: The "◇" symbol at the end of the title indicates that the article contains multiple stock issues.

Source: MINKABU PRESS

Related Articles